NASDAQ:XERS

Xeris Pharmaceuticals Stock Insider Trading

etoro logo Buy XERS
*Your capital is at risk
$8.16
-0.180 (-2.16%)
At Close: Jul 13, 2026

Xeris Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -47.96. In total, the insiders bought 3.59M and sold 1.97M XERS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-47.96
Buy 3.59M shares
Sell 1.97M shares
48% Buy Activity
Moderate Negative Correlation
Sell Signal Medium Confidence
Jul 01, 2026

Analysis Breakdown:

  • Supported by a negative Insider Power Score of -47.96.
  • Partially supported by a negative historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jul 07, 2026
Sell
Common Stock
S-Sale
Pieper Steven
See Remarks
Officer 27 600
Value: $235.3K
Jul 06, 2026
Sell
Common Stock
S-Sale
Pieper Steven
See Remarks
Officer 17 400
Value: $147.9K
Jul 01, 2026
Buy
Common Stock
A-Award
Kreher Nerissa
Director
Director 33 582
Value: $268.7K
Jul 01, 2026
Buy
Stock Option (Right to Buy)
A-Award
Kreher Nerissa
Director
Director 37 910
Value: $303.3K
Jul 01, 2026
Buy
Common Stock
J-Other
Kreher Nerissa
Director 0
Value: $0
Jul 01, 2026
Sell
Common Stock
S-Sale
Mcculloch Kevin
See Remarks
Officer 90 000
Value: $722.5K
Jul 01, 2026
Sell
Common Stock
S-Sale
Hecht Beth
See Remarks
Officer 16 666
Value: $133.9K
Jun 04, 2026
Buy
Stock Option (Right to Buy)
A-Award
Brady James Aloysius
Director
Director 32 996
Value: $202.9K
Jun 04, 2026
Buy
Common Stock
A-Award
Brady James Aloysius
Director
Director 24 193
Value: $148.8K
Jun 04, 2026
Buy
Stock Option (Right to Buy)
A-Award
Johnson John
Director
Director 32 996
Value: $202.9K
Jun 04, 2026
Sell
Common Stock
S-Sale
Johnson John
Director
Director 15 000
Value: $91.4K
Jun 04, 2026
Buy
Stock Option (Right to Buy)
A-Award
Bormann-kennedy Barbara-jean Anne
Director
Director 32 996
Value: $202.9K
Jun 04, 2026
Buy
Stock Option (Right to Buy)
A-Award
Halkuff Dawn
Director
Director 32 996
Value: $202.9K
Jun 04, 2026
Sell
Common Stock
S-Sale
Halkuff Dawn
Director
Director 20 000
Value: $121.9K
Jun 04, 2026
Buy
Stock Option (Right to Buy)
A-Award
Persky Marla
Director
Director 32 996
Value: $202.9K
Jun 04, 2026
Buy
Common Stock
A-Award
Kong Garheng
Director
Director 24 193
Value: $148.8K
Jun 04, 2026
Buy
Stock Option (Right to Buy)
A-Award
Kong Garheng
Director
Director 32 996
Value: $202.9K
Jun 04, 2026
Buy
Common Stock
A-Award
Persky Marla
Director
Director 24 193
Value: $148.8K
Jun 04, 2026
Buy
Common Stock
A-Award
Halkuff Dawn
Director
Director 24 193
Value: $148.8K
Jun 04, 2026
Buy
Common Stock
A-Award
Bormann-kennedy Barbara-jean Anne
Director
Director 24 193
Value: $148.8K
Jun 04, 2026
Sell
Common Stock
S-Sale
Bormann-kennedy Barbara-jean Anne
Director
Director 16 000
Value: $97.5K
Jun 04, 2026
Buy
Common Stock
A-Award
Johnson John
Director
Director 24 193
Value: $148.8K
Jun 03, 2026
Sell
Common Stock
S-Sale
Persky Marla
Director
Director 15 500
Value: $91.4K
Jun 01, 2026
Sell
Common Stock
S-Sale
Hecht Beth
See Remarks
Officer 16 667
Value: $101.0K
May 01, 2026
Sell
Common Stock
S-Sale
Hecht Beth
See Remarks
Officer 16 667
Value: $103.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT XERIS PHARMACEUTICALS INC
Xeris Pharmaceuticals
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhi...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE